Sponsor:
Mount Sinai Hospital, Canada
Code:
NCT06805773
Conditions
Sarcoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
Educational videos
Standard of Care
Brief summary:
Conditions
Sarcoma
Study ID
NCT06805773
Start date
May 5, 2025
Status verified date
Oct, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Dec, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: Educational Videos
other: Standard of Care
Interventions
Educational videos
Standard of Care
Primary outcome measure
Central contacts
Locations
Mount Sinai Hospital
Recruiting
Toronto, Ontario, Canada, M5G 1X5
Contacts
Principal Investigator:
Geoffrey Watson
Sponsor
Mount Sinai Hospital, Canada
Last update posted
Oct 14, 2026
Last verified
Oct, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-25. This information was provided to ClinicalTrials.gov by Mount Sinai Hospital, Canada on 2026-10-14. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.